Roadblocks and Red Tape Block Search for Cures
Since its passage more than two years ago, the JOBS Act has spurred more than 110 biotech IPOs. And now the SEC is in the process of finalizing another important piece of the law that could further...
View ArticleBiotech Analyst Optimism: Price Targets Post-IPO
In a recent blog post, Bruce Booth of Life Sci VC, writes about the relationship between a forecasted price target of a biotech stock and its current share price. If biotech stocks hit their current...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
State of the Industry for Emerging Therapeutic Companies
Emerging therapeutic companies are at their strongest point in a decade. In our new report on investment and deal trends, the BIO Industry Analysis team shows how this segment within the biotech...
View Article
More Pages to Explore .....
